SION compared with CLYM: revenue, margins and what each company keeps, and the suppliers and customers both name

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

CLYMClimb Bio, Inc.

Mkt capRevenueRevenue

Compare

SIONSionna Therapeutics, Inc.

CLYMClimb Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SION

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+4.80%—

May 12 '26±10.9%▼−10.90%×1.00

Q1 FY26—▼−7.17%—

Nov 5 '25—▼−1.57%—

CLYM2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±23.9%▼−4.93%×0.21

Q2 FY26±40.4%▲+12.27%×0.30

= impliedSION realized, solidCLYM realized, hatchedOne scale, both sides: full bar = 41%× = |realized| ÷ impliedspan: SION 274d · CLYM 91dSource: market data

SIONSionna Therapeutics, Inc.

3.25▼−0.91%

Mkt cap$168.4M

CLYMClimb Bio, Inc.

9.97▲+12.38%

Regular sessionNov 6 '26

Mkt cap$521.0M

Compare

Regular sessionNov 6 '26

SIONSionna Therapeutics, Inc.

CLYMClimb Bio, Inc.

3.25▼−0.91%

Price

9.97▲+12.38%

$168.4M

Mkt cap

$521.0M

SION3.25▼−0.91%vsCLYM9.97▲+12.38%Regular sessionNov 6 '26